Enabling Genomic Technologies and Screening Asia 2014
September 11 - 12, 2014
Suntec City , Singapore
Select Biosciences South East Asia is delighted to announce that our Enabling Genomic Technologies and Screening Asia Conference and Exhibition will take place at the Biopolis, Singapore on the 11th and 12th September 2014
.
We are honoured to have Dr. Hakim Djaballah, Director of the High-Throughput Drug Screening Facility, at the Memorial Sloan Kettering Cancer Center as our Conference Chairman.
We are hosting the event at A*STAR’s state of the art conference facilities within the Biopolis, the Biomedical Science hub for Singapore. The event will have two concurrent conference tracks, with presentations from the leading scientists within these fields.
The first conference track will cover Enabling Genomic Technologies and we are proud to welcome both Professor David Virshup and Dr. Kosuke Yusa as our Keynote Speakers for the meeting. Professor Virshup is the inaugural Director of the Cancer and Stem Cell Biology Program at the Duke-NUS Graduate Medical School in Singapore. Dr. Kosuke Yusa is a member of the Sanger Institute Faculty, UK. We will be discussing the following topics; Gene & pathway discovery with RNAi, Genome editing with CRISPRs, TALENs and ZFNs, miRNAs, long non-coding RNAs, & epigenetic control, Genomics big data sets and bioinformatics tools.
The second track is entitled Screening Asia and we are privileged to have both Dr. Alex Matter, M.D., and Dr. Litao Zhang, as our Keynote Speakers. Dr. Matter is the CEO of the Experimental Therapeutics Centre, A*STAR, Singapore. Dr Litao Zhang is the Vice President of Leads Discovery and Optimization, Bristol-Myers Squibb. We will be covering the following subject areas; High content assay discovery, 3D cellular model systems, Target-based discovery, Natural Products.
.
We are honoured to have Dr. Hakim Djaballah, Director of the High-Throughput Drug Screening Facility, at the Memorial Sloan Kettering Cancer Center as our Conference Chairman.
We are hosting the event at A*STAR’s state of the art conference facilities within the Biopolis, the Biomedical Science hub for Singapore. The event will have two concurrent conference tracks, with presentations from the leading scientists within these fields.
The first conference track will cover Enabling Genomic Technologies and we are proud to welcome both Professor David Virshup and Dr. Kosuke Yusa as our Keynote Speakers for the meeting. Professor Virshup is the inaugural Director of the Cancer and Stem Cell Biology Program at the Duke-NUS Graduate Medical School in Singapore. Dr. Kosuke Yusa is a member of the Sanger Institute Faculty, UK. We will be discussing the following topics; Gene & pathway discovery with RNAi, Genome editing with CRISPRs, TALENs and ZFNs, miRNAs, long non-coding RNAs, & epigenetic control, Genomics big data sets and bioinformatics tools.
The second track is entitled Screening Asia and we are privileged to have both Dr. Alex Matter, M.D., and Dr. Litao Zhang, as our Keynote Speakers. Dr. Matter is the CEO of the Experimental Therapeutics Centre, A*STAR, Singapore. Dr Litao Zhang is the Vice President of Leads Discovery and Optimization, Bristol-Myers Squibb. We will be covering the following subject areas; High content assay discovery, 3D cellular model systems, Target-based discovery, Natural Products.
Venue
Location: Biopolis Singapore
Contact
30 Biopolis Street Matrix Building 138671 Suntec City , Singapore
+65 6560 0056
+65 6560 0056
Related events
Enabling Genomic Technologies and Screening Asia September 11 - 12, 2014
